The landscape of managing diabetes is evolving with the emergence of skin-applied GLP-1 therapy. These innovative devices offer a potentially less invasive alternative to shots for individuals managing diabetes mellitus type 2 . They deliver a GLP-1 agonist directly through the dermis , bypassing